The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: velcade     Quarter: 2016Q3

Total Records: 602     Number of Pages: 31

DRUGNAME PT EventCount
VELCADE Blood bilirubin increased 3
VELCADE Blood creatine phosphokinase increased 3
VELCADE Blood lactate dehydrogenase increased 3
VELCADE Blood potassium increased 3
VELCADE Bone pain 3
VELCADE Bronchospasm 3
VELCADE Burning sensation 3
VELCADE Cardiomegaly 3
VELCADE Cholangiocarcinoma 3
VELCADE Colitis 3
VELCADE Condition aggravated 3
VELCADE Conjunctivitis bacterial 3
VELCADE Coronary artery disease 3
VELCADE Dermo-hypodermitis 3
VELCADE Device related infection 3
VELCADE Dialysis 3
VELCADE Disseminated intravascular coagulation 3
VELCADE Dysgeusia 3
VELCADE Epistaxis 3
VELCADE Escherichia sepsis 3

Total Records: 602     Number of Pages: 31